Viewing nowCombinationDURAB Tablet 60/2.5 mg (Pimasartan potassium, Esamlodipine)
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Nexpam Korea Co., Ltd.

MFDS item code 202300109 · Approved 2023.01.06 · Insurance code 662504830
Treatment of essential hypertension not controlled with fimasartan monotherapy
This medication is used in patients with essential hypertension in whom blood pressure is not adequately controlled by monotherapy with Pimasartan potassium.
The recommended dose is 1 tablet once daily, taken with water regardless of meals. It is recommended to take the tablet at the same time each day, if possible (e.g., in the morning). It is recommended to adjust the dose of fimasartan before administering this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. No initial dose adjustment is necessary for elderly patients aged 70 years or younger. No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. No dose adjustment is necessary in patients with mild hepatic impairment. However, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.
This medicine can cause serious harm to the fetus and newborn when taken during pregnancy, especially in the second and third trimesters, so you should stop taking it immediately once pregnancy is confirmed. Patients who have an allergy to any component of this medication or those with certain kidney and liver diseases, bile duct obstruction, or severe aortic stenosis should not use this medicine. Patients with reduced blood volume or sodium deficiency, impaired kidney function, renal artery hypertension, etc., should be closely monitored while taking this medicine, as there may be occurrences of hypotension or worsening kidney function. While taking this medicine, side effects such as dizziness, headache, facial or peripheral edema, urinary disturbances, insomnia, and flushing may occur. If symptoms are severe or persistent, you should consult a healthcare professional. It is important to regularly check blood pressure and potassium levels as there is a risk of hypotension and electrolyte imbalances, particularly hyperkalemia. This medicine may interact with other antihypertensive agents, diuretics, potassium-sparing diuretics, potassium supplements, etc., so inform your healthcare provider of any other medications you are taking. Pregnant or breastfeeding individuals should consult a healthcare professional before taking this medicine, and if breastfeeding, they are advised to stop breastfeeding or discontinue the medicine. The safety and efficacy in children and adolescents under 18 years old have not been established, thus its use is not recommended. Elderly patients may react more sensitively to this medicine, so caution is needed during administration. In cases of overdose, severe hypotension, palpitations, and shock may occur; immediate medical attention is required.
Dizziness, orthostatic dizziness, headache, facial edema, peripheral edema, urinary disturbances, insomnia, flushing, syncope, tranquility, migraine, indigestion, vomiting, nausea, upper abdominal pain, weakness, foreign body sensation, elevated liver enzyme levels, reduced platelet count, increased serum creatine phosphokinase, cough, muscle contraction, musculoskeletal stiffness, itching, localized urticaria, facial flushing, erectile dysfunction, epilepsy, amyotrophic lateral sclerosis, neuropathy, neurocytolysis, facial paralysis, normal pressure hydrocephalus, spinal stenosis, acute pancreatitis, intestinal obstruction, hemorrhagic duodenal ulcer, appendicitis, hemorrhoids, abdominal pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, worsening cerebral infarction, cerebral hemorrhage, liver cancer, colorectal carcinoma, neoplasm of unspecified type, cervical cancer, prostate cancer, acute renal failure, chronic renal failure, kidney stones, pyelonephritis, urinary incontinence, rhinitis, pulmonary fibrosis, pharyngitis, pneumonia, lung disease, death, exacerbation of low back pain, osteoarthritis, joint disease, hypoglycemia, hyperkalemia, pulmonary embolism, purpura, bradycardia, atrial fibrillation, coronary artery disease, aortic stenosis, heart failure, elevated blood pressure, acute hepatitis, benign pituitary neoplasm, otitis media, uterine prolapse, recurrent cancer, fracture, chest pain, weakness, fatigue, pain, weight gain, weight loss, hypotension, vasculitis, tension increase, sensory decrease, sensory abnormalities, peripheral neuropathy, taste distortion, tremor, extrapyramidal disorders, gynecomastia, change in bowel habits, dry mouth, gastritis, gingival hypertrophy, pancreatitis, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, cough, dyspnea, rhinitis, hair loss, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, nocturia, hepatitis, jaundice, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, hypotension, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, erythematous lesions, maculopapular rash, heaviness, warmth sensation, impaired glucose tolerance, weakness, symptoms of hypotension due to depletion of blood volume and sodium, increased serum potassium level, increased serum creatinine, increased blood urea nitrogen, decreased blood pressure, shock symptoms, loss of consciousness, dyspnea, severe hypotension, pulmonary edema, blood pressure fluctuations, elevated blood pressure, purpura, fatty liver, intestinal vascular edema, abdominal pain, nausea, vomiting, diarrhea
Not everyone experiences these, and they can vary from person to person.
This medicine is sensitive to light, so it should be stored in a container that protects it from light. Additionally, it is important to maintain a storage temperature between 1 to 30 degrees Celsius.
Yellow, round-edged square film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Nexpam Korea Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.